Year: 2025
Type: article
Abstract: The rise of compounded weight-loss drugs has emerged as a pressing global health issue, threatening consumers and health-care systems. Factors fueling this crisis include the desire for rapid weight-loss options, inadequate regulatory frameworks, and the easy availability of compounded products through online platforms and social media. Vulnerable populations, particularly those searching for low-cost treatments, are hit hardest. Tackling this escalating problem calls for a comprehensive strategy: enhancing regulatory oversight, raising public awareness, and fostering stakeholder collaboration. We can reduce the health dangers of compounded weight-loss medications by addressing the underlying causes and improving consumer safety. This article examines the risks associated with compounded weight-loss drugs and suggests practical measures to protect public health.
Source: Journal of the Endocrine Society
Authors: Nikhil Sood, Rohini Garg
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,255
OpenAlex ID: W4411121807